BlackRock Institutional Trust’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

BlackRock Institutional Trust’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$27.2M	Buy	545,612 +26,027	+5%	+$1.39M	﹤0.01%	1751
2016 Q3	$31.2M	Buy	519,585 +125,984	+32%	+$7.26M	﹤0.01%	1583
2016 Q2	$20.1M	Buy	393,601 +65,167	+20%	+$2.78M	﹤0.01%	1844
2016 Q1	$9.69M	Buy	328,434 +58,026	+21%	+$1.83M	﹤0.01%	2275
2015 Q4	$12.3M	Buy	270,408 +10,481	+4%	+$549K	﹤0.01%	2198
2015 Q3	$10.8M	Buy	259,927 +94,169	+57%	+$4.91M	﹤0.01%	2239
2015 Q2	$9.99M	Sell	165,758 -5,374	-3%	-$355K	﹤0.01%	2414
2015 Q1	$13.3M	Buy	+171,132	New	+$9.86M	﹤0.01%	2211

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SMV

Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Institutional Trust's ONCE Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Spark Therapeutics, Inc. Common Stock (ONCE) stake by 5% in Q4 2016, buying an estimated $1.39M and bringing the position to 545,612 shares worth $27.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

BlackRock Institutional Trust first reported a position in ONCE in Q1 2015 and has held it in 8 quarters since. The position peaked at $31.2M in Q3 2016. 119 funds tracked by Wall St. Rank hold ONCE as of Q4 2016.

BlackRock Institutional Trust held 545,612 shares of Spark Therapeutics, Inc. Common Stock worth $27.2M as of Q4 2016.
BlackRock Institutional Trust bought 26,027 Spark Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $1.39M.
Spark Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1751 holding.
BlackRock Institutional Trust first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and has held it in 8 quarters since.
BlackRock Institutional Trust's Spark Therapeutics, Inc. Common Stock position peaked at $31.2M in Q3 2016.
119 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.